ORTHOVISC® INJECTION, 2mL
$52.00
ORTHOVISC is an ultra-pure, high molecular weight injectable hyaluronic acid (HA) viscosupplement used to treat the joint pain caused by osteoarthritis.
Brand: ORTHOVISC®
Manufacturer: Anika Therapeutics
Active Substances: SODIUM HYALURONATE
Strength: 15mg/ml
Pack Size: 2 x 1ml Pre-Filled Syringes
Additional information
Orthovisc Injection is a non-animal-derived, high-molecular-weight hyaluronic acid product designed for intra-articular injections to relieve pain caused by osteoarthritis. It functions by restoring the natural lubrication and shock-absorbing properties of the synovial fluid within joints.
This clinically proven therapy is particularly suitable for patients seeking a minimally invasive treatment option to enhance their quality of life. Manufactured by Anika Therapeutics, Orthovisc® is trusted worldwide for its efficacy and safety profile in managing joint pain.
Main Treatment Areas
Orthovisc® Injection is primarily indicated for:
- Osteoarthritis pain relief, especially in the knee joint.
- Restoring the natural viscosity of synovial fluid to reduce joint friction.
- Enhancing mobility and functionality in patients with joint disorders.
Key Benefits
- Long-Lasting Relief: A series of injections provide sustained pain relief, helping patients manage osteoarthritis symptoms effectively.
- Enhanced Lubrication: Mimics the natural synovial fluid to improve joint function and reduce friction.
- Non-Animal Derived: Reduces the risk of allergic reactions, making it suitable for a broad range of patients.
- Improved Mobility: Enhances overall joint health and movement, allowing patients to maintain an active lifestyle.
Safety Information
Orthovisc is generally well-tolerated, with minimal side effects. Common reactions may include mild pain, swelling, or stiffness at the injection site. It is contraindicated in patients with infections or skin conditions near the injection area or those with hypersensitivity to hyaluronic acid. For optimal safety, always consult with a licensed healthcare provider before use. Avoid use in pregnant or breastfeeding individuals unless deemed necessary by a physician.
Orthovisc Wholesale Information
Orthovisc is available at competitive wholesale prices, ensuring cost-effective solutions for clinics and healthcare professionals. For small orders, the price starts at $52.00 per unit for quantities between 1 to 5 units. Bulk purchases offer significant savings, with prices reduced to $49.00 per unit for 6 to 10 units, $47.00 per unit for 11 to 20 units, and as low as $45.00 per unit for orders of 21 or more. Partner with trusted wholesale suppliers like Dr. Sales Direct to access these discounts and optimize your practice’s inventory management with high-quality products at exceptional prices.
Frequently Asked Questions
Orthovisc injections can provide knee pain relief for up to six months. The exact duration may vary depending on individual factors such as the severity of osteoarthritis and the patient’s activity level.
Yes, Orthovisc is considered a good gel injection for treating knee osteoarthritis. It is a high molecular weight hyaluronic acid that provides effective lubrication and cushioning for the knee joint, reducing pain and improving joint function.
Orthovisc acts as a lubricant and shock absorber for the knee joint. It helps reduce pain and improve mobility by restoring the cushioning properties of the synovial fluid, which is often compromised in osteoarthritis.
Orthovisc is a non-animal-derived hyaluronic acid injection, while Synvisc contains hylan G-F 20, a cross-linked derivative of hyaluronic acid. Synvisc tends to have superior viscoelastic properties for better cushioning but may cause more inflammatory reactions compared to Orthovisc/
Orthovisc requires a series of three to four weekly injections, while Monovisc is designed for single-injection treatment. Both are made from hyaluronic acid but differ in their administration schedules and specific formulations.
Euflexxa and Orthovisc are both non-animal-derived hyaluronic acid injections used to treat osteoarthritis pain by enhancing joint lubrication and cushioning. Euflexxa is typically administered in a series of three weekly injections, providing effective pain relief and improved mobility, particularly for knee osteoarthritis.
Orthovisc, known for its high molecular weight and ultra-pure formulation, is given as a series of three or four weekly injections, also primarily targeting knee osteoarthritis. Both treatments aim to reduce pain and enhance joint function, with the choice depending on patient response and physician preference.
